At the inaugural meeting of the UK Working Party on Transfusion-Associated Hepatitis it was decided that they should collate data which determined the importance of NANBH in the UK and should consider the implications of surrogate markers. Read more about At the inaugural meeting of the UK Working Party on Transfusion-Associated Hepatitis it was decided that they should collate data which determined the importance of NANBH in the UK and should consider the implications of surrogate markers.
The inaugural meeting of the UK Working Party on Transfusion-Associated Hepatitis took place. It was agreed that a request would be made for a member of the DHSS's Advisory Group on Hepatitis to attend meetings. Read more about The inaugural meeting of the UK Working Party on Transfusion-Associated Hepatitis took place. It was agreed that a request would be made for a member of the DHSS's Advisory Group on Hepatitis to attend meetings.
At the UKHCDO annual meeting there was a passing discussion of AIDS. No DHSS officials were present. Read more about At the UKHCDO annual meeting there was a passing discussion of AIDS. No DHSS officials were present.
At a meeting of the MRC's Blood Transfusion Research Committee Dr Gunson thought the committee needed to "justify its existence", whilst the DHSS favoured its continuance. Read more about At a meeting of the MRC's Blood Transfusion Research Committee Dr Gunson thought the committee needed to "justify its existence", whilst the DHSS favoured its continuance.
At a meeting of the MRC's Blood Transfusion Research Committee, it was agreed that there was "at present no need to screen potential blood donors for non-A non-B hepatitis" but the production of a vaccine would be waited with interest, and that it would be valuable to follow-up transfusion patients previously found to have a raised serum level. Read more about At a meeting of the MRC's Blood Transfusion Research Committee, it was agreed that there was "at present no need to screen potential blood donors for non-A non-B hepatitis" but the production of a vaccine would be waited with interest, and that it would be valuable to follow-up transfusion patients previously found to have a raised serum level.
A note setting out the terms of reference and proposed members of the Hepatitis Advisory Group referred to "problems relating to the management and prevention of non-A non-B hepatitis." Read more about A note setting out the terms of reference and proposed members of the Hepatitis Advisory Group referred to "problems relating to the management and prevention of non-A non-B hepatitis."
The Maycock Group agreed to set up the Hepatitis Advisory Group (HAG). Its terms of reference were "to provide medical advice to the Chief Medical Officers of the Health Departments of the United Kingdom on all aspects of communicable hepatitis." Read more about The Maycock Group agreed to set up the Hepatitis Advisory Group (HAG). Its terms of reference were "to provide medical advice to the Chief Medical Officers of the Health Departments of the United Kingdom on all aspects of communicable hepatitis."
The MRC's Blood Transfusion Research Committee was reconstituted and met for the first time. Read more about The MRC's Blood Transfusion Research Committee was reconstituted and met for the first time.
The Advisory Group on Testing for the Presence of Hepatitis B Surface Antigen and its Antibody considered whether to make any alterations to the methods used for testing blood donations.. Read more about The Advisory Group on Testing for the Presence of Hepatitis B Surface Antigen and its Antibody considered whether to make any alterations to the methods used for testing blood donations..
The Advisory Group on Testing for the Presence of Hepatitis B Surface Antigen and its Antibody (the Maycock Group) published a revised version of its first report. Read more about The Advisory Group on Testing for the Presence of Hepatitis B Surface Antigen and its Antibody (the Maycock Group) published a revised version of its first report.